International Journal of Advanced and Integrated Medical Sciences

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  3 (2018)
Volume  2 (2017)
Volume  1 (2016)
Related articles

VOLUME 2 , ISSUE 4 ( 2017 ) > List of Articles

ORIGINAL ARTICLE

Prevalence of Impacted Mandibular Third Molars in an East Indian Subpopulation: A Retrospective Radiographic Study

Sumit Mohan, Virender K Prajapati, Ajoy Shahi

Keywords : Angulation, Pell and Gregory classification, Third molar impaction

Citation Information : Mohan S, Prajapati VK, Shahi A. Prevalence of Impacted Mandibular Third Molars in an East Indian Subpopulation: A Retrospective Radiographic Study. Int J Adv Integ Med Sci 2017; 2 (4):175-177.

DOI: 10.5005/jp-journals-10050-10100

License: CC BY-SA 4.0

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2017; The Author(s).


Abstract

The purpose of this retrospective radiographic study was to evaluate the position of mandibular third molars. This study was conducted at the Dental Institute, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand. Patients who had reported with the complaint of pain and swelling in the lower third molar area were assessed and advised orthopantomograph (OPG) for their lower third molar. These were evaluated according to Pell and Gregory classification. Of the total 600 patients examined, 300 were males and 300 were females. Most of the patients were between 30 and 39 years of age (n = 250). It was observed that position I (n = 313) and class II (55% n = 324) were found to be the most common. How to cite this article Mohan S, Prajapati VK, Shahi A. Prevalence of Impacted Mandibular Third Molars in an East Indian Subpopulation: A Retrospective Radiographic Study. Int J Adv Integ Med Sci 2017;2(4):175-177.

PDF Share
  1. Bouloux GF, Steed MB, Perciaccante VJ. Complications of third molar surgery. Oral Maxillofac Surg Clin North Am 2007 Feb;19(1):117-128.
  2. Stathopoulos P, Mezitis M, Kappatos C, Titsinides S, Stylogianni E. Cyst and tumors associated with impacted third molars: is prophylactic removal justified. J Oral Maxillofac Surg 2011 Feb;69(2):405-408.
  3. Howe GL, Poyton HG. Prevention of damage to the inferior alveolar nerve during extraction of mandibular third molars. Br Dent J 1960;109(1):355-356.
  4. Obiechina AE. Update in the technique of third molar surgery. Ann Ib Postgrad Med 2003;1(1):40-45.
  5. Hochwald DA, Davis WH, Mortinoff JM. Modified distolingual splitting technique for removal of impacted mandibular third molars Incidence of postoperative sequelae. Oral Surg Oral Med Oral Pathol 1983 Jul;56(1):9-12.
  6. Pell GJ, Gregory BT. Impacted mandibular third molars: classification and modified techniques for removal. Dent Digest 1933;39(2):330-338.
  7. Almendros-Marqués N, Alaejos-Algarra E, Quinteros-Borgarello M, Berini-Aytés L, Gay-Escoda C. Factors influencing the prophylactic removal of asymptomatic impacted lower third molars. Int J Oral Maxillofac Surg 2008 Jan;37(1):29-35.
  8. Gbotolorun OM, Olojede AC, Arotiba GT, Ladeinde AL, Akinwande JA, Bamgbose BO. Impacted mandibular third molars: presentation and post operative complications at the Lagos University Teaching Hospital. Nig Q J Hosp Med 2007 Jan-Mar;17(2):26-29.
  9. Sandhu S, Kaur T. Radiographic evaluation of the status of third molars in the Asian-Indian students. J Maxillofac Surg 2005 May;63(2):640-645.
  10. Nanda RS, Chawla TN. Status of third molar teeth. J Dent Assoc 1959 Feb;31(2):19-29.
  11. Hattab FN, Rawashdeh MA, Fahmy MS. Impaction status of third molars in Jordanian students. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995 Jan;79(1):24-29.
  12. Hugoson A, Kugelberg CF. The prevalence of third molars in a Swedish population. An epidemiological study. Community Dent Health 1988 Jun;5(2):121-138.
  13. Hassan AH. Pattern of third molar impaction in Saudi population. Clin Cos Invest Dent 2010;2(2):109-113.
  14. Monaco G, Montevecchi M, Bonetti GA, Gatto MR, Checchi L. Reliability of panoramic radiography in evaluating the topographic relationship between the mandibular canal and impacted third molar. J Am Dent Assoc 2004 Mar;135(1):312-318.
  15. Jerjes W, El-Maaytah M, Swinson B. Inferior alveolar nerve injury and surgery difficulty prediction in third molar surgery: the role of panomaric radiography. J Clin Dent 2006;17(2):122-130.
  16. Susarla SM, Dodson TB. Estimating third molar extraction difficulty: a comparison of subjective and objective factors. J Oral Maxillofac Surg 2005 Apr;63(4): 427-434.
  17. Clovis M, Eliston C, Filhio T, Lopes J. Third molar classification in the north west of Santa Catarina state of Brazil. Rev Odonto Ciencia 2006;21(2):55-66.
  18. Jafar RO, Tin-Oo MM. Impacted third molars among patients attending hospital university Sains Malasyia. Arch Orofac Sci 2009;4(1):7-12.
  19. Khan A, Khaitab U, Khan MT. Impacted mandibular third molar: pattern of presentations and post operative complication. Pak Oral Dent J 2010;30(1):307-312.
  20. Lindelof B, Islam N, Eklund G, Arfors L. Pemphigoid and cancer. Arch Dermatol 1990 Jan;126(1):66-68.
  21. Dahl MV, Ristow S. Bullous pemphigoid and ovarian cystadenocarcinoma: immunologic studies. Arch Dermatol 1978 Jun;114(6):903-905.
  22. Daoud, MS.; Pittelkow, MR. Pityriasis lichenoides. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1999. pp. 553-560.
  23. Litt, JZ. Drug eruption reference manual. New York: Parthenon Publishing; 1998. p. 564.
  24. Tosi A, Misciali C, Piraccini B, Peluso AM, Bardazzi F. Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Saf 1994 Apr;10(4):310-317.
  25. Bronner AK, Hood AF. Cutaneous complication of chemotherapeutic agents. J Am Acad Dermatol 1983 Nov;9(5):645-663.
  26. Hood AF. Cutaneous side effects of cancer chemotherapy. Med Clin North Am 1986 Jan;70(1):187-209.
  27. Boyle DM, Engelking C. Vesicant extravasation: myths and realities. Oncol Nurs Forum 1995 Jan-Feb;22(1):57-67.
  28. Malkinson, FD. Radiobiology of the skin. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, editors. Fitzpatrick's dermatology in general medicine. 5th edn. New York: McGraw-Hill; 1999. pp. 1514-1523.
  29. Goldschmidt H, Breneman JC, Bareneman DL. Ionizing radiation therapy in dermatology. J Am Acad Dermatol 1994 Feb;30(2 Pt 1):157-182.
  30. Narkiewicz K, van de Borne P, Montano N, Hering D, Kara T, Somers VK. Sympathetic neural outflow and chemoreflex sensitivity are related to spontaneous breathing rate in normal men. Hypertension 2006;47(1):51-55.
  31. Agte VV, Chiplonkar SA. Sudarshan kriya yoga for improving antioxidant status and reducing anxiety in adults. Altern Complement Ther 2008;14(2):96-100.
  32. Jacobs GD. Clinical applications of the relaxation response and mind-body interventions. J Altern Complement Med 2001;7(Suppl 1):S93-S101.
  33. Singh N, Telles S. Heart rate variability and state anxiety in hypertensives and diabetes after one week of yoga. J Indian Psychol 2009;27(1-2):13-20.
  34. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Sever PS, McG Thom S; British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV. J Hum Hypertens 2004 Mar;18(3):139-185.
  35. Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, Myers MG, McKay DW, Quinn RR, Hemmelgarn BR, et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011 Jul-Aug;27(4):415-433.e1-2.
  36. Wahlgren NG, MacMahon DG, De Keyser JF, Indredavik B, Ryman T. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 1994 May;4(3):204-10.
  37. Kaste M, Fogelholm R, Erilä T, Palomäki H, Murros K, Rissanen A, Sarna S. A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke. Stroke 1994 Jul;25(7):1348-1353.
  38. Schrader J, Lüders S, Kulschewski A, Berger J, Zidek W, Treib J, Einhaupl K, Diener HC, Dominiak P; Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. The ACCESS study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003 Jul;34(7):1699-1703.
  39. Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011 Feb;377(9767):741-750.
  40. Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, Jagger C. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 2009 Jan;8(1):48-56.
  41. Robinson TG, Potter JF, Ford GA, Bulpitt CJ, Chernova J, Jagger C, James MA, Knight J, Markus HS, Mistri AK, et al. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol 2010 Aug;9(8):767-775.
  42. Jauch EC, Saver JL, Adams HP, Bruno A, Demaerschalk BM, Khatri P, McMullan PW, Qureshi AI, Rosenfield K, Scott PA, et al. Guidelines for the early management of patients with acute ischemic stroke. Stroke 2013 Mar;44(3):870-947.
  43. Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, Lees KR, Toni D; SITS Investigators. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis. Stroke 2009 Jul;40(7):2442-2449.
  44. Karachalios GN, Charalabopoulos A, Papalimneou V, Kiortsis D, Dimicco P, Kostoula OK, Charalabopoulos K. Withdrawal syndrome following cessation of antihypertensive drug therapy. Int J Clin Pract 2005 May;59(5):562-570.
  45. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001 Sep;358(9287):1033-1041.
  46. Schrader J, Lüders S, Kulschewski A, Hammersen F, Plate K, Berger J, Zidek W, Dominiak P, Diener HC; MOSES Study Group. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention. Stroke 2005 Jun;36(6):1218-1226.
  47. Yusuf S, Diener HC, Sacco RL, Cotton D, Ôunpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008 Sep;359(12):1225-1237.
  48. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2014 Jan:45(7):2160-2236.
  49. Robb AO, Mills NL, Din JN, Smith IB, Paterson F, Newby DE, Denison FC. Influence of the menstrual cycle, pregnancy, and preeclampsia on arterial stiffness. Hypertension 2009 Jun;53(6):952-958.
  50. Avni B, Frenkel G, Shahar L, Golik A, Sherman D, Dishy V. Aortic stiffness in normal and hypertensive pregnancy. Blood Press 2010 Feb;19(1):11-15.
  51. Khalil A, Akolekar R, Syngelaki A, Elkhouli M, Nicolaides KH. Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia. Ultrasound Obstet Gynecol 2012 Jul;40(1):28-34.
  52. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992 Feb;304(6824):405-412.
  53. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002 Mar;359(9311):995-1003.
  54. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trials-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005 Sep;366(9489):895-906.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.